Zehentmayr, F; Klebermass, M; Zellinger, B; Langer, B; Grambozov, B; Purevdorj, A; Karner, J; Gruber, G; Stana, M; Minasch, D; Kirchhammer, K; Steffal, C; Stranzl, H; Moosbrugger, R; Feurstein, P; Dieckmann, K; Ruznic, E.
Immunotherapy improves clinical outcome in KRAS mutated patients with unresectable NSCLC stage III: A subcohort analysis of the Austrian radio-oncological lung cancer study association regristry (ALLSTAR)
J THORAC ONCOL. 2025; 20(3):
Web of Science